Rosiglitazone monotherapy is effective in patients with type 2 diabetes (vol 86, pg 280, 2001)

被引:0
|
作者
Lebovitz, HE
Dole, JF
Patwardhan, R
Rappaport, EB
Freed, MI
机构
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1659 / 1659
页数:1
相关论文
共 50 条
  • [1] Rosiglitazone monotherapy is effective in patients with type 2 diabetes
    Lebovitz, HE
    Dole, JF
    Patwardhan, R
    Rappaport, EB
    Freed, MI
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (01): : 280 - 288
  • [2] Rosiglitazone monotherapy and Type 2 diabetes
    Lawrence, IG
    DIABETIC MEDICINE, 2001, 5 : 6 - 8
  • [3] Rosiglitazone is effective and well tolerated as monotherapy in African Americans with type 2 diabetes
    Osei, K
    Miller, EE
    Everitt, DE
    Ilgenfritz, J
    Porter, LE
    Freed, MI
    DIABETES, 2001, 50 : A127 - A128
  • [4] Rosiglitazone in the treatment of Type 2 Diabetes Mellitus: A critical review (vol 22, pg 1151, 2001)
    Malinowski, J
    Bolesta, S
    CLINICAL THERAPEUTICS, 2001, 23 (02) : 309 - 309
  • [5] Rosiglitazone is effective in poorly controlled type 2 diabetes patients.
    Goldstein, B
    Salzman, A
    DIABETOLOGIA, 1999, 42 : A229 - A229
  • [6] Dietary Sodium Intake in Patients with Type 2 Diabetes Mellitus (vol 40, pg 280, 2016)
    Kim, Mi-Kyung
    DIABETES & METABOLISM JOURNAL, 2017, 41 (01) : 79 - 79
  • [7] Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes (vol 24, pg 308, 2001)
    Phillips, LS
    Grunberger, G
    Miller, E
    Patwardhan, R
    Rappaport, EB
    Salzman, A
    DIABETES CARE, 2001, 24 (05) : 973 - 973
  • [8] Three studies in type 2 diabetes: ADOPT Rosiglitazone monotherapy in type 2 diabetes: what indication?
    Roussel, R.
    ANNALES D ENDOCRINOLOGIE, 2007, 68 : S28 - S32
  • [9] Renal Function in Type 2 Diabetes with Rosiglitazone, Metformin, and Glyburide Monotherapy
    Lachin, John M.
    Viberti, Giancarlo
    Zinman, Bernard
    Haffner, Steven M.
    Aftring, R. Paul
    Paul, Gitanjali
    Kravitz, Barbara G.
    Herman, William H.
    Holman, Rury R.
    Kahn, Steven E.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (05): : 1032 - 1040
  • [10] Rosiglitazone monotherapy for type 2 diabetes mellitus—too soon to ADOPT?
    Peter Gæde
    Oluf Pedersen
    Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 456 - 457